JP Morgan Chase’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

JP Morgan Chase’s Portfolio ELAT Stock Details ELAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25,000	Closed	-$488K	–	7517
2022 Q4	$488K	Buy	+25,000	New	+$503K	﹤0.01%	4540
2022 Q3	–	Sell	-35,000	Closed	-$1.12M	–	7081
2022 Q2	$1.12M	Buy	+35,000	New	+$1.32M	﹤0.01%	3993
2022 Q1	–	Sell	-47,335	Closed	-$2.11M	–	7215
2021 Q4	$2.11M	Buy	47,335 +44,709	+1,703%	+$2.15M	﹤0.01%	3821
2021 Q3	$131K	Buy	+2,626	New	+$137K	﹤0.01%	5434

JP Morgan Chase's ELAT Position: Q1 2023 in Review

JP Morgan Chase sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 25,000 shares — an estimated $488K sold.

JP Morgan Chase first reported a position in ELAT in Q3 2021 and held it in 4 quarters. The position peaked at $2.11M in Q4 2021. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

JP Morgan Chase reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
JP Morgan Chase sold 25,000 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $488K.
JP Morgan Chase first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q3 2021 and held it in 4 quarters.
JP Morgan Chase's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $2.11M in Q4 2021.
0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.